Common goal: More powerful immunotherapies against cancer

Mainz, August 10, 2018 – The new Helmholtz Institute “HI-TRON Mainz” aims to develop effective immunotherapies and identify new biomarkers for cancer treatments.
HI-TRON is a collaboration between the German Cancer Research Center (DKFZ) and the research institute TRON – Translational Oncology at the University Medical Center of Johannes Gutenberg University Mainz. Cooperation agreements have now been signed.

“By founding of HI-TRON Mainz, we are pursuing the mission of establishing a world-leading center for personalized cancer immunotherapy. HI-TRON Mainz thus engenders the Helmholtz spirit by acting as a catalyst for groundbreaking technologies, sustainable translation of academic innovation and its clinical implementation for the benefit of patients, “so Ugur Sahin, founder and scientific director of TRON.

Please find further details in the official press release and in an article on transkript.de